Hikma Pharmaceutical | HIK - Assets


Hikma Pharmaceutical reported $5.67B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Almirall EUR 2.34B 29.21M Dec/2025
argenx SE USD 7.18B 973.07M Jun/2025
AstraZeneca USD 114.07B 382M Dec/2025
Autolus Therapeutics Ltd USD 589.07M 72.88M Dec/2025
Bayer EUR 104.54B 331M Dec/2025
Fresenius EUR 42.46B 1.14B Sep/2025
Galapagos EUR 3.41B 105.39M Dec/2025
Genmab DKK 12.87B 5.85B Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
GRIFOLS EUR 19.71B 141.77M Dec/2025
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Lonza CHF 18.97B 164M Dec/2025
Merck EUR 51.53B 600M Dec/2025
Orion EUR 2.01B 262M Dec/2025
Recordati EUR 5.3B 122.58M Sep/2025
Roche Holding CHF 100.7B 5.94B Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
UCB EUR 18.16B 971M Dec/2025